Link to this page

Your search term(s) "Erectile Dysfunction" returned 25 results.

Page 1 2 3    Display All

Pelvic Floor Muscle Exercises and Manometric Biofeedback for Erectile Dysfunction and Postmicturition Dribble: Three Case Studies. Journal of WOCN. Wound, Ostomy, and Continence Nurses Society. 30(1): 44-52. January 2003.

This article presents three successful case studies of men receiving treatment for erectile dysfunction (ED, formerly called impotence) and postmicturition dribble (leakage of urine immediately after urination). The authors focus on the benefits of pelvic floor muscle exercises (PFME) for these men. Each of the three subjects reported normal erectile function following PFME and manometric biofeedback. Manometric biofeedback was chosen as a reliable method of monitoring anal pressure measurements. PFME, which included a 'squeeze out' pelvic floor muscle contraction after voiding urine, alleviated the small amount of postmicturition dribble experienced by two subjects. These case studies are reported to alert professionals to the possibility of the benefits of PFME for some men. A commentary is appended to the article. 2 figures. 3 tables. 20 references.

Full Record   Printer Friendly Version

Salvage of Sildenafil Failures Referred From Primary Care Physicians. Journal of Urology. 170(6): 2356-2358. December 2003.

Sildenafil citrate (Viagra) is an effective first line agent for most causes of erectile dysfunction (ED). Primary care providers (PCPs) write the majority of these prescriptions and most failures of sildenafil therapy are subsequently referred to urologists for alternative therapies. Often it is concluded that the drug is ineffective when in actuality the failure is due to inadequate patient education. This article reports on a study of patients referred from PCPs who were nonresponders to sildenafil therapy and who the authors attempted to convert to responders through re-education. Of the 253 patients re-educated, 17 were excluded due to contraindications. Of the remaining nonresponders, 41.5 percent achieved salvage with re-education. Incorrect administration accounted for 81 percent of the failures. Average time with the physician was 12 minutes and 94 percent of the patients continued to respond at 26 months. The authors conclude that new package materials may improve sildenafil outcomes and compliance. 1 appendix. 2 figures. 3 tables. 10 references.

Full Record   Printer Friendly Version

Sexual Function in Men Older Than 50 Years of Age: Results from the Health Professionals Follow-up Study. Annals of Internal Medicine. 139(3): 161-168. August 2003.

Although many studies have provided data on erectile dysfunction (ED, formerly called impotence) in specific settings, few studies have been large enough to precisely examine age-specific prevalence and correlates. This article reports on a study undertaken to describe the association between age and several aspects of sexual functioning in men older than 50 years of age. The cross-sectional analysis of data from a prospective cohort study included 31,742 men, aged 53 to 90 years. Questionnaires mailed in 2000 asked about sexual function, physical activity, body weight, smoking, marital status, medical conditions, and medications. When men with prostate cancer were excluded, the results showed age-standardized prevalence of ED in the previous 3 months was 33 percent. Many aspects of sexual function (included overall function, desire, orgasm, and overall ability) decreased sharply by decade after 50 years of age. Physical activity was associated with lower risk for ED and obesity was associated with higher risk. Smoking, alcohol consumption, and television viewing time were also associated with increased prevalence of ED. Men who had no chronic medical conditions and who engaged in healthy behaviors had the lowest prevalence of ED. The authors concludes that several modifiable health behaviors are associated with maintenance of good erectile function. 1 figure. 4 tables. 33 references.

Full Record   Printer Friendly Version

Smoking and Erectile Dysfunction: How Strong a Link?. Contemporary Urology. 15(3): 34, 36-38, 40. March 2003.

Although the exact effect of smoking on penile function remains unclear, numerous studies suggest a correlation between smoking and erectile dysfunction (ED, formerly called impotence). This article examines what is currently known, and what remains to be discovered, about this link. ED is defined as the inability to achieve and maintain a penile erection sufficient for sexual intercourse. Topics include the physiology of erection, clinical evidence linking smoking and ED, the effect of smoking cessation, epidemiological evidence, and the interplay of smoking and oral pharmacotherapy (notably with sildenafil, Viagra). The authors conclude that more basic science and clinical investigation is necessary to ascertain the exact effects that smoking has on erectile function. 1 table. 28 references.

Full Record   Printer Friendly Version

Use of Medications for Erectile Dysfunction in the United States, 1996 Through 2001. Journal of Urology. 169(3): 1040-1042. March 2003.

This article reports on a review of the use during 1996 through 2001 of the primary medications approved in the United States for treatment of erectile dysfunction (ED), namely alprostadil injection and urethral suppository, and oral sildenafil (Viagra). Increases in the number of dispensed prescriptions for alprostadil injection and urethral suppository marketed in 1995 and 1996, respectively, were reversed in 1998 by the marketing of sildenafil. Sildenafil was prescribed proportionately more frequently for younger men than alprostadil injection or suppository. Alprostadil was prescribed proportionately more frequently by urologists than sildenafil, which was most commonly prescribed by family and general practitioners, and internists. The data indicate the wide adoption and use of sildenafil for erectile dysfunction. 3 tables. 18 references.

Full Record   Printer Friendly Version

Page 1 2 3    Display All

Start a new search.